NGM·Industrials·$375M·#15 / 255 in Industrials

SBC SBC Medical Group Holdings Inco

80SOLID

CATEGORY BREAKDOWN

GROWTH10
QUALITY95
STABILITY98
VALUATION94
GOVERNANCE100

METRIC BREAKDOWN

Revenue Growth (YoY)

Year-over-year revenue growth rate

+6.1%
10

> 50% strong

Gross Margin

Revenue retained after direct costs

76.0%
100

> 50% strong

Cash Runway

Months of cash at current burn rate

999 months
100

> 24 months ideal

Debt / Equity

Total debt relative to shareholder equity

6.3%
95

< 25% strong

Price / Sales

Market cap relative to trailing revenue

2.1x
94

< 3x strong

Rule of 40

Growth rate plus operating margin

48
88

> 40 excellent

Insider Ownership

Percentage of shares held by insiders

90.4%
100

> 20% strong

Share Dilution (12M)

Share count increase over last 12 months

-0.4%
100

< 5% ideal

5 more metrics available

Unlock all 8 metrics, score history, watchlist, and side-by-side comparison.

Try Free for 30 Days

AI ANALYSIS REPORT

AI-GENERATED

BUSINESS SUMMARY

SBC Medical Group Holdings Inco (SBC) is a industrials company trading on NGM with a market capitalization of $375M. The company currently carries a SOLID rating of 80/100, indicating above-average fundamental quality. The fundamental profile shows modest single-digit revenue growth at 6.1% year-over-year, paired with strong gross margins well above industry average at 76.0%. The balance sheet shows minimal leverage with a very low debt-to-equity ratio, and the company has effectively infinite cash runway, indicating operational self-sufficiency.

VERDICT

SBC scores 80/100 — a solid fundamental profile with room for improvement in select areas. This report is based on the latest available financial data and is intended as a starting point for research, not a buy or sell recommendation.

MARKET OPPORTUNITY

In the industrial sector, margins above 40% are unusual and suggest proprietary technology or high-value niches. Growth at this level is rare for industrials. SBC Medical Group Holdings Inco operates with very high insider ownership of 90.4%, showing extreme management conviction, which provides a signal about management's confidence in the company's direction. At a market cap of $375M, the company is attractively valued at under 3x price-to-sales at 2.1x P/S. The combination of these factors positions SBC as a potentially interesting opportunity for investors seeking fundamental quality in the small-cap space.

REVENUE QUALITY

Revenue growth stands at 6.1% year-over-year, which is in line with the typical small-cap growth rate. Gross margins of 76.0% are strong and suggest pricing power or an asset-light business model. The Rule of 40 score of 48 exceeds the benchmark of 40, confirming efficient growth. Cash runway is effectively infinite, meaning the company generates enough cash to sustain operations without external funding.

COMPETITIVE ADVANTAGE

Evaluating SBC Medical Group Holdings Inco's competitive position requires looking beyond the numbers. The 90.4% insider ownership is a strong positive signal — when management has significant personal wealth tied to the company, decisions tend to favor long-term value creation over short-term metrics. The high gross margins suggest some form of competitive moat — whether through proprietary technology, brand value, regulatory barriers, or network effects. The company is actively buying back shares, which typically signals management believes the stock is undervalued. Investors should research the specific sources of competitive advantage — patents, customer switching costs, scale economies, or brand — that could protect margins over time.

GROWTH THESIS

SBC presents a reasonable fundamental case at current levels. The low 2.1x P/S ratio could represent value if the company can stabilize or accelerate its growth. The 90.4% insider ownership creates strong alignment between management and shareholders. The self-funding business model means growth isn't dependent on external capital, reducing dilution risk. Key catalysts to watch include: revenue growth trajectory over the next 2-3 quarters, margin expansion or contraction, and any changes in insider buying or selling activity.

KEY RISKS

Small-cap stocks carry inherently higher risk than large-caps, including limited analyst coverage, lower institutional ownership, and higher sensitivity to market downturns. Always conduct thorough due diligence beyond quantitative metrics.

Full AI Report available

Unlock the complete analysis including market opportunity, revenue quality, competitive moat, growth thesis, and risk assessment.

Try Free for 30 Days

Report generated: Mar 26, 2026

SCORE HISTORY

Track how this score changes over time. Start your free trial to see the full score trend chart.

SCORE ALERT

Get notified when SBC's score changes by 5+ points.

DATA INFO

Last updated: Mar 11, 2026

Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.